The SENS-U KIDS is a small wearable device that provides warning when the bladder is nearly full. SENSE-U KIDS helps children to stay dry during day and night and will improve the effectiveness of continence training by teaching the child the sensation of a full bladder.

Novuxion offers a non-invasive, inexpensive method of testing patients. We aim to provide in vitro diagnostic technology to enable (early) detection of metastatic cancer, patient monitoring, and therapy adjustment.

Novya Biotech accelerates yeast-based production platforms with a groundbreaking CRISPR-based technology, enabling faster and more cost-effective production of complex pharmaceutical compounds.

Small Molecules for Targeted Anti-Cancer Therapy

Cells and tissues often depend on vascular networks to supply essential nutrients—but in many clinical and industrial contexts, this natural support system is absent. NuNa Bioscience is developing NutriX, a patented and cell-triggered nutrient release platform that helps preserve metabolism outside the body.

To develop immunomodulatory ingredients with evidence-based health benefits for (medical) foods, dietary supplements and animal feeds.

Nydus R&D develops the first human-relevant brainstem organoid platform to transform drug testing for deadly pediatric brain cancers like DMG, bridging the gap between lab research and clinical success.

OcellO offers in vitro assays which recapitulate and quantify complex human biology in a robust and high-throughput format.
We test compounds for oncology, immuno-oncology, inflammation and cystopathy indications.

CellEKT presents a revolutionary approach to kinase inhibitor screening, addressing a critical gap in the drug discovery process.

Omnicin Therapeutics develops Bismocin, an inhaled therapy that restores antibiotic effectiveness against resistant Pseudomonas aeruginosa lung infections in chronic respiratory patients.